Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus

Vet Microbiol. 2013 Aug 30;165(3-4):333-40. doi: 10.1016/j.vetmic.2013.04.017. Epub 2013 Apr 23.

Abstract

The aim of the present study was to assess the effect of introducing a priming step with replication-defective viral vectors encoding the capsid proteins of FMDV, followed by a boost with killed virus vaccines, using a suitable BALB/c mice model. Additionally, the immune response to other combined vector immunization regimens was studied. For this purpose, we analyzed different prime-boost immunizations with recombinant adenovirus (Ad), herpesvirus amplicons (Hs) and/or killed virus (KV) vaccines. The highest antibody titers were found in the group that received two doses of adjuvanted KV (P<0.002). Antibody titers were higher in those groups receiving a mixed regimen of vectors, compared to immunization with either vector alone (P<0.0001). Priming with any of the viral vectors induced a shift of the cytokine balance toward a Th1 type immune response regardless of the delivery system used for boosting. The highest IgG1 titer was induced by two doses of adjuvanted KV (P=0.0002) and the highest IgG2a titer corresponded to the group primed with Ad and boosted with KV (P=0.01). Re-stimulation of all groups of mice with 0.5 μg of inactivated virus five months later resulted in a fast increase of antibody titers in all the groups tested. After virus stimulation, antibody titers in the groups that received KV alone or Ad prime-KV boost, were indistinguishable (P=0.800). Protection from challenge was similar (75%) in the groups of animals that received Ad prime-Hs boost or Ad prime-KV boost, or two doses of oil-adjuvanted KV. The data presented in this study suggest that sequential immunization with viral vectors-based vaccines combined with protein-based vaccines have the potential to enhance the quality of the immune response against FMDV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / immunology*
  • Animals
  • Antibodies, Viral / blood
  • Capsid Proteins / genetics
  • Capsid Proteins / immunology*
  • Disease Models, Animal
  • Foot-and-Mouth Disease / immunology*
  • Foot-and-Mouth Disease / prevention & control
  • Foot-and-Mouth Disease Virus / genetics
  • Foot-and-Mouth Disease Virus / immunology*
  • Genetic Vectors / genetics
  • HEK293 Cells
  • Herpesviridae / genetics
  • Herpesviridae / immunology
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Vaccination / veterinary*
  • Vaccines, Inactivated / immunology*
  • Viral Vaccines / genetics
  • Viral Vaccines / immunology*
  • Virus Inactivation
  • Virus Replication / genetics

Substances

  • Antibodies, Viral
  • Capsid Proteins
  • Immunoglobulin G
  • Vaccines, Inactivated
  • Viral Vaccines